Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities

• Main Authors: Angela T. Estadt (Author), David Kline (Author), William C. Miller (Author), Judith Feinberg (Author), Christopher B. Hurt (Author), L. Sarah Mixson (Author), Peter D. Friedmann (Author), Kelsa Lowe (Author), Judith I. Tsui (Author), April M. Young (Author), Hannah Cooper (Author), P. Todd Korthuis (Author), Mai T. Pho (Author), Wiley Jenkins (Author), Ryan P. Westergaard (Author), Vivian F. Go (Author), Daniel Brook (Author), Gordon Smith (Author), Dylan R. Rice (Author), Kathryn E. Lancaster (Author)
• Format: Book
• Published: BMC, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background People who use drugs (PWUD) in rural communities increasingly use stimulants, such as methamphetamine and cocaine, with opioids. We examined differences in hepatitis C virus (HCV) testing and treatment history among rural PWUD with opioids, stimulants, and other substance use com...